HealthLynked Receives $500,000
Payment Milestone from Sale of ACO Health Partners
Naples,
FL -- November 25, 2024 -- InvestorsHub NewsWire
-- HealthLynked
Corp. (OTCQB: HLYK), a leader in healthcare technology
and patient engagement solutions, today announced the receipt of
$500,000 in scheduled sale consideration related to the January
2023 sale of ACO Health Partners (AHP). This payment represents
HealthLynked's contractual share of the shared savings generated by
AHP's Accountable Care Organization (ACO) during the 2023
performance period.
Since the sale of AHP in
January 2023, HealthLynked has received a total of $3 million in
gross proceeds. This includes an initial $750,000 from the sale,
$1.75 million in participation-based payments, and the $500,000
received this week. These payments represent the full amount of
cash consideration HealthLynked was eligible to receive under the
terms of the sale agreement.
Dr. Michael Dent, CEO of
HealthLynked, stated, "The sale of our ACO to Palm Beach ACO was a
strategic step forward for HealthLynked, enabling us to focus on
expanding our core healthcare technology and patient engagement
services. We are delighted to see that the ACO continues to deliver
meaningful benefits to patients and providers, underscoring the
value of this collaborative care model."
For more information
about HealthLynked, please visit
www.healthlynked.com.
About HealthLynked
Corp
HealthLynked Corp. enhances healthcare through personalized care
management that improves outcomes and reduces costs. Its
cloud-based platform connects patients with providers for virtual
or in-office appointments and consolidates medical records into one
secure, accessible location.
With
AI-driven recommendations, HealthLynked offers tailored insights,
streamlines care coordination, and provides savings on
prescriptions and medical supplies. By empowering patients with
efficient, affordable solutions, HealthLynked delivers better care
and an improved healthcare experience.
Forward-Looking Statements & Risk
Factors
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such forward looking statements are subject to risks and
uncertainties that are often difficult to predict, are beyond our
control and which may cause results to differ materially from
expectations. Actual results may differ materially from those
expressed or implied by these statements due to various risks and
uncertainties. Without limiting the foregoing, forward-looking
statements may be identified by terms such as "may," "expect,"
"intend," "anticipate," "believe," "estimate," and similar
expressions. These statements are based on assumptions deemed
reasonable but are inherently uncertain and cannot be guaranteed.
We do not undertake any obligation to update these statements
except as required by law. For more information, please refer to
the "Risk Factors" section of our latest Annual Report on Form 10-K
and other filings available at www.sec.gov.
Contact Information:
HealthLynked Corp.
Michael Paisan
1265 Creekside
Parkway, Suite 301
Naples, FL 34118
Email: IR@healthlynked.com
Phone: +1 (800) 928-7144